Hypertension. Essential (primary) hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with a body mass index higher than 25 Regular use of antihypertensive drugs for at least the last 3 months non-smoker Haven't been under any weight-loss diet at least 3 months before participating in the study
Exclusion criteria
Exclusion criteria: Taking antipsychotic, anticonvulsant drugs Cancer or stage 4 or 5 chronic or kidney disease Pregnancy or breastfeeding Any changes in the disease treatment plan during the study, including changes in the type and dose of drugs used to affect blood pressure or surgery• Insulin treated patients Taking omega 3 supplement
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: Baseline and the end of study. Method of measurement: Validated digital arm sphygmomanometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Plasma brain-derived neurotrophic factor. Timepoint: Baseline and the end of study. Method of measurement: ?»]??.;Plasma ICAM-1. Timepoint: Baseline and the end of study. Method of measurement: ELISA. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Beheshti University of Medical Sciences